Scholar Rock Holding (SRRK) Other financing activities (2018 - 2026)
Scholar Rock Holding's (SRRK) quarterly Other financing activities came in at $3.5 million in Q1 2026, down 30.82% year-on-year from $5.0 million in Q1 2025, and down 85.41% quarter-over-quarter from $23.8 million in Q4 2025.
Scholar Rock Holding (SRRK) Other financing activities (2018 - 2026) Analysis & Trends
Scholar Rock Holding's Other financing activities history runs 9 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- On a quarterly basis, Other financing activities fell 30.82% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $22.3 million, a 56.5% increase from a year earlier, with the FY2025 full-year figure at $23.8 million, up 147.39% from the prior year.
- Other financing activities slipped to $3.5 million in Q1 2026 per SRRK's latest filing, from $23.8 million in the prior quarter.
- Across five years, Other financing activities topped out at $23.8 million in Q4 2025 and bottomed at -$3.4 million in Q3 2025.
- The 5-year median for Other financing activities is $419000.0 (2024), against an average of $2.7 million.
- Across the five-year window, Other financing activities jumped 568600.0% in 2024 and plunged 129.07% in 2025, its largest moves.
- Year by year, Other financing activities stood at $5000.0 in 2022, then jumped by 69100.0% to $3.5 million in 2023, then climbed by 1.71% to $3.5 million in 2024, then surged by 576.58% to $23.8 million in 2025, then slumped by 85.41% to $3.5 million in 2026.
- Per Business Quant, the three latest SRRK Other financing activities figures stand at $3.5 million (Q1 2026), $23.8 million (Q4 2025), and -$3.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.47 Mn |
| Mar 31, 2026 | 3.47 Mn |
| Dec 31, 2025 | 23.81 Mn |
| Dec 31, 2025 | 23.81 Mn |
| Sep 30, 2025 | -3.37 Mn |
| Sep 30, 2025 | -3.37 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Jun 30, 2024 | 5.69 Mn |
| Jun 30, 2024 | 5.69 Mn |
| Mar 31, 2024 | 419,000.00 |
| Mar 31, 2024 | 419,000.00 |
| Dec 31, 2023 | 3.46 Mn |
| Dec 31, 2023 | 3.46 Mn |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |